Skip to content

The Analgesic Effect of Transversus Abdominis Plane (TAP) Block Following Radical Prostatectomy

The Analgesic Effect of Transversus Abdominis Plane (TAP) Block Versus Wound Infiltration Versus Placebo Following Open Radical Prostatectomy, a Double Blinded, Randomized Clinical Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01317368
Enrollment
75
Registered
2011-03-17
Start date
2011-03-31
Completion date
2012-02-29
Last updated
2012-06-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Pain

Keywords

Postoperative analgesic treatment, TAP block, Prostatectomy, Double blinded randomized clinical trial

Brief summary

This study is conducted to evaluate different analgesic treatments effect following operation where the prostate gland is surgically removed. The different treatments the investigators wish to investigate is: 1. Transversus Abdominis Plane (TAP) block. The TAP block is a rather new method, where a local anaesthetic is deposited between the two inner abdominal muscles. Between these muscles, the nerves that innervates the anterior part of the abdominal wall is situated. 2. Wound infiltration In this method you deposit a local anaesthetic in the edges of the wound. 3. Placebo No active local treatment is given. All patients who wish to participate will be allocated to one of three different treatment groups. Group 1: Will receive TAP block with a local anaesthetic and wound infiltration with saline. Group 2: Will receive wound infiltration with a local anaesthetic and TAP block with saline. Group 3: Will receive TAP block with saline and wound infiltration with saline. Beside this local treatment all patients will be given systemic Paracetamol (tablet) and Ibuprofen (tablet). In addition all patients will be given a pump containing morphine. The pump is connected to a button which the patient can activate when they experience pain. This enables the patient to control how much morphine he needs, following the operation. The hypothesis is that the TAP block is superior in reducing pain and thereby reducing morphine consumption compared to wound infiltration and placebo.

Interventions

DRUGNaropine

20 mL of 0,75% Naropin is deposited on each side (40 mL in total) in the TAP. At the same time 40 mL of saline 0,9% will be deposited subcutaneously as wound infiltration. Both procedures is carried out at the end of the surgery while the patient is still anaesthetized and only this once.

OTHERPlacebo

20 mL 0,9% Saline is deposited on each side (40 mL in total) in the TAP. At the same time 40 mL Saline 0,9% will be given as wound infiltration. Both procedures is carried out at the end of the surgery while the patient is still anaesthetized and only this once.

Sponsors

Rigshospitalet, Denmark
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
MALE
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* BMI \> 18 and \< 35 * Patients who have given their informed consent and have fully understood the nature and limitations of the study * Patient who is planned for radical prostatectomy

Exclusion criteria

* Not able to cooperate to complete the study * Is not able to speak and understand danish * Allergy towards the drugs which is used in the study * Daily use of strong opioids * Infection at the injection area

Design outcomes

Primary

MeasureTime frame
A mean visual analogue scale (VAS) pain score 4 hours after surgery when moving from a supine to sitting position between the group receiving active TAP block and the placebo group.4 hours postoperative

Secondary

MeasureTime frameDescription
VAS pain score when moving from a supine to a sitting position, recorded as a Area under Curve (AUC/24h)Recorded 0-24 hours postoperativeThis outcome is assessed 1, 2, 4, 6, 8, 20 and 24 hours postoperative. This outcome is recorded in and compared between all three groups.
NauseaRecorded 0-24 hours postoperativeOn a scale ranging none-mild-moderate-severe at 1, 2, 4, 6, 8, 20, 24 hours postoperative. This outcome is recorded in and compared between all three groups
SedationRecorded at 0-24 hours postoperativeOn a scale ranging none-mild-moderate-severe this outcome is assessed at 1, 2, 4, 6, 8, 20 and 24 hours postoperative. This outcome is recorded in and compared between all three groups.
VAS pain score at rest, recorded as a Area Under Curve (AUC/24h)Recorded 0-24 hours postoperativeThis outcome is assessed 1, 2, 4, 6, 8, 20 and 24 hours postoperative, while the patient is supine in his bed. This outcome is recorded in and compared between all three groups.
On-going morphine consumptionRecorded 0-24 postoperativeRecorded at the intervals 0-1, 1-2, 2-4, 4-6, 6-8, 8-20 and 20-24 hours postoperative This outcome is recorded and compared between all three groups
Cumulated morphine consumption24 hours postoperativeThis outcome is recorded in and compared between all three groups.
VomitingRecorded 0-24 hours postoperativeThe number of times the patient produces more than 10 mL of vomit. Recorded at the intervals 0-1, 1-2, 2-4, 4-6, 6-8, 8-20 and 20-24 hours postoperative This outcome is recorded in and compared between all three groups

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026